Viva Biotech Holdings (VBIZF)
USD 0.23
(-24.16%)
USD 0.23
(-24.16%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -116.11 Million CNY | 78.03% |
| 2022 | -528.47 Million CNY | -283.79% |
| 2021 | 287.54 Million CNY | 174.32% |
| 2020 | -386.88 Million CNY | -245.51% |
| 2019 | 265.87 Million CNY | 193.62% |
| 2018 | 90.55 Million CNY | 18.74% |
| 2017 | 76.26 Million CNY | 211.61% |
| 2016 | 24.47 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 8.03 Million USD | 0.0% |
| 2024 Q1 | 8.08 Million USD | 149.93% |
| 2023 FY | -116.11 Million CNY | 78.03% |
| 2023 Q1 | 73.75 Thousand USD | 100.12% |
| 2023 Q2 | 146.15 Thousand USD | 98.17% |
| 2023 Q3 | -8.02 Million USD | -5588.32% |
| 2023 Q4 | -16.2 Million USD | -101.97% |
| 2022 FY | -528.47 Million CNY | -283.79% |
| 2022 Q4 | -61.68 Million USD | -100.74% |
| 2022 Q3 | -30.73 Million USD | -101.76% |
| 2022 Q2 | -15.23 Million USD | 0.0% |
| 2021 Q4 | 31.43 Million USD | 0.0% |
| 2021 FY | 287.54 Million CNY | 174.32% |
| 2021 Q2 | 13.13 Million USD | 0.0% |
| 2020 Q2 | -75.49 Million USD | 0.0% |
| 2020 Q4 | 21.16 Million USD | 0.0% |
| 2020 FY | -386.88 Million CNY | -245.51% |
| 2019 Q2 | 6.87 Million USD | 0.0% |
| 2019 Q4 | 31.34 Million USD | 0.0% |
| 2019 FY | 265.87 Million CNY | 193.62% |
| 2018 FY | 90.55 Million CNY | 18.74% |
| 2017 FY | 76.26 Million CNY | 211.61% |
| 2016 FY | 24.47 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -3.81 Million USD | -2940.403% |
| Skye Bioscience, Inc. | -37.64 Million USD | -208.444% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 278.271% |
| Nascent Biotech, Inc. | -2.08 Million USD | -5461.814% |
| Qrons Inc. | -789.34 Thousand USD | -14610.007% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -27846.78% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -1562.834% |
| BioStem Technologies, Inc. | -8.48 Million USD | -1268.775% |
| Regen BioPharma, Inc. | 1.02 Million USD | 11444.611% |
| CSL Limited | 2.64 Billion USD | 104.395% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -85.487% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 319.168% |
| Rebus Holdings, Inc. | -1.02 Million USD | -11283.627% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -8594.796% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -18260.486% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -631.584% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -54.894% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -1665.679% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -42369.697% |
| SQZ Biotechnologies Company | -79.46 Million USD | -46.12% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -3914.425% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -6277.985% |
| Mesoblast Limited | -87.95 Million USD | -32.013% |
| Marizyme, Inc. | -65.34 Million USD | -77.687% |
| Genus plc | 7.9 Million USD | 1569.785% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -966.065% |
| Pharming Group N.V. | -10.54 Million USD | -1000.806% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -5251.288% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -3029.533% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -1212.901% |
| ContraFect Corporation | -65.15 Million USD | -78.216% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -2276.412% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -6621.622% |
| IMV Inc. | -36.48 Million USD | -218.243% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -1340.665% |
| MultiCell Technologies, Inc. | -380.07 USD | -30550324.922% |
| ONE Bio Corp. | 8.67 Million USD | 1438.23% |
| Accustem Sciences Inc. | -3.74 Million USD | -2999.306% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -124.625% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -9063.435% |
| Q BioMed Inc. | -2.05 Million USD | -5558.272% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -3010.447% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -4776.915% |
| Biomind Labs Inc. | -1.21 Million USD | -9461.985% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -94.411% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -3643.446% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -1369.21% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -5856.807% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -775227.19% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -1896.011% |
| GB Sciences, Inc. | -1.36 Million USD | -8427.206% |
| Alpha Cognition Inc. | -13.77 Million USD | -743.074% |
| HST Global, Inc. | -146.21 Thousand USD | -79315.225% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -6516.989% |
| Halberd Corporation | -79.67 Thousand USD | -145631.462% |
| Enzolytics Inc. | -2.17 Million USD | -5234.036% |
| Agentix Corp. | -1.37 Million USD | -8349.43% |
| Resverlogix Corp. | -3.61 Million USD | -3116.427% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -3561.212% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 60.647% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 118582.653% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 1776.82% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -2822.557% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -3737.007% |
| AVAX Technologies, Inc. | -6.41 Million USD | -1710.405% |
| Zenith Capital Corp. | -10.59 Million USD | -995.819% |
| Genscript Biotech Corporation | -95.47 Million USD | -21.614% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -499482.652% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -2700.646% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -192010.9% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -5690.84% |
| Kadimastem Ltd | -3.3 Million USD | -3410.705% |
| Helix BioMedix, Inc. | -1.05 Million USD | -10894.956% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -26207.466% |
| LadRx Corporation | 400.44 Thousand USD | 29096.137% |
| Cell Source, Inc. | -5.32 Million USD | -2082.078% |
| Regen BioPharma, Inc. | 1.02 Million USD | 11444.611% |
| NovAccess Global Inc. | -4.76 Million USD | -2334.65% |
| Affymax, Inc. | -14.42 Million USD | -704.999% |
| Itoco Inc. | -1.86 Million USD | -6112.59% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -2513.665% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -6857.04% |
| Mobile Lads Corp. | -2.26 Million USD | -5030.27% |
| CytoDyn Inc. | -49.84 Million USD | -132.967% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -146817.111% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -50798.403% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -12232.387% |
| SYBLEU INC | -180.3 Thousand USD | -64298.46% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -7099.748% |
| International Stem Cell Corporation | -131 Thousand USD | -88535.878% |
| Bioxytran, Inc. | -4.28 Million USD | -2612.919% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -213846.418% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -4488.999% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -141.54% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -5392.573% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -14769.373% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -3565.183% |
| Neutra Corp. | -233.46 Thousand USD | -49634.65% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -472.239% |
| PureTech Health plc | -65.69 Million USD | -76.74% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -445.989% |
| IXICO plc | -1.17 Million USD | -9756.791% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -1069.669% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -103.251% |
| CSL Limited | 2.64 Billion USD | 104.395% |
| Cellectis S.A. | -103.17 Million USD | -12.541% |